Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

CCC Project - Atrial Fibrillation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02309398
Recruitment Status : Completed
First Posted : December 5, 2014
Last Update Posted : January 27, 2021
Sponsor:
Collaborators:
American Heart Association
Chinese Society of Cardiology
Information provided by (Responsible Party):
Dong ZHAO, Beijing Institute of Heart, Lung and Blood Vessel Diseases

Brief Summary:
The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.

Condition or disease
Atrial Fibrillation

Layout table for study information
Study Type : Observational
Actual Enrollment : 67028 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Atrial Fibrillation
Study Start Date : January 2015
Actual Primary Completion Date : December 2020
Actual Study Completion Date : December 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. The overall composite of six performance measures for AF care [ Time Frame: Duration of hospital stay, an expected average of 1 week ]

    Performance measures for AF care including:

    1. Proportion of patients received assessment of thromboembolic risk factors
    2. Proportion of patients discharged on warfarin or other anticoagulant drug
    3. Proportion of patients discharged on warfarin who have PT/INR follow-up planned prior to hospital discharge
    4. Proportion of patients with left ventricular systolic dysfunction prescribed an ACEI or ARB at hospital discharge
    5. Proportion of patients with left ventricular systolic dysfunction prescribed a beta blocker at hospital discharge
    6. Proportion of patients with either coronary artery disease, cerebrovascular accident/transient ischemic attack, peripheral vascular disease or diabetes who were prescribed a statin at hospital discharge



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hospitalized patients of atrial fibrillation
Criteria

Inclusion Criteria:

  • Hospitalized patients with discharge diagnosis as atrial fibrillation in 150 tertiary and 100 secondary hospitals.

Exclusion Criteria:

None


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02309398


Locations
Layout table for location information
China
Beijing An Zhen Hospital
Beijing, China
Sponsors and Collaborators
Beijing Institute of Heart, Lung and Blood Vessel Diseases
American Heart Association
Chinese Society of Cardiology
Investigators
Layout table for investigator information
Principal Investigator: Dong Zhao, Ph. D Beijing Institute of Heart, Lung and Blood Vessel Diseases
Additional Information:
Publications of Results:
Layout table for additonal information
Responsible Party: Dong ZHAO, Principal Investigator, Beijing Institute of Heart, Lung and Blood Vessel Diseases
ClinicalTrials.gov Identifier: NCT02309398    
Other Study ID Numbers: CCC-AF-2014
First Posted: December 5, 2014    Key Record Dates
Last Update Posted: January 27, 2021
Last Verified: January 2021
Additional relevant MeSH terms:
Layout table for MeSH terms
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes